Predictive Tests for Stress Urinary Incontinence After Pelvic Organ Prolapse Surgery
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores ways to predict and prevent stress urinary incontinence (urine leakage during activities like coughing) that may occur after pelvic organ prolapse surgery. It compares two methods: a preoperative test where a doctor checks for leaks when a patient coughs (Preoperative Prolapse Reduction Cough Stress Test) and an intraoperative maneuver that checks for leaks during surgery (Intraoperative Crede Manoeuver). The trial aims to determine which method better predicts and prevents urinary issues, thereby improving patients' quality of life. Women with significant pelvic organ prolapse requiring surgery, but without a history of stress urinary incontinence, might be suitable candidates for this trial. As an unphased trial, this study provides an opportunity to contribute to important research that could enhance surgical outcomes and quality of life for future patients.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that these methods are safe for predicting stress urinary incontinence?
Research has shown that the intraoperative Crede maneuver is generally safe. This technique involves gently pressing on the bladder during surgery to check for urine leaks. Studies have found it to be a simple and safe method.
The preoperative prolapse reduction cough stress test is another safe and straightforward procedure performed before surgery. In this test, a healthcare provider checks for urine leaks by having the patient cough while gently pushing back any bulging pelvic organs.
Both methods help predict and prevent urinary incontinence (loss of bladder control) after surgery. Reports of significant problems with either technique are absent, making them well-tolerated options.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it seeks to improve the decision-making process during pelvic organ prolapse surgery, particularly in determining the need for additional anti-incontinence procedures. Traditionally, stress urinary incontinence is managed with surgeries like sling procedures, but identifying patients who will benefit from these interventions can be challenging. The trial evaluates methods like the preoperative prolapse reduction cough stress test and the intraoperative Crede maneuver, which aim to predict incontinence risk more accurately. By enhancing predictive accuracy, these techniques could lead to more tailored and effective surgical plans, potentially reducing unnecessary procedures and improving patient outcomes.
What evidence suggests that these methods are effective for predicting stress urinary incontinence after pelvic organ prolapse surgery?
In this trial, participants will undergo one of two predictive tests for stress urinary incontinence (SUI) following pelvic organ prolapse surgery. Research has shown that the intraoperative Crede maneuver, one of the tests in this trial, can predict SUI. Specifically, one study indicated it predicted SUI in about 32.5% of women after surgery, suggesting its usefulness in deciding whether to perform additional procedures during surgery to prevent incontinence. The other test, the preoperative prolapse reduction cough stress test, is used before surgery to check for signs of SUI. These tests assist doctors in determining if preventive steps are needed before surgery. Both methods aim to reduce the risk of developing urinary incontinence post-surgery.12367
Who Is on the Research Team?
Maryse Larouche, MD, MPH
Principal Investigator
St. Mary's Research Centre and RI-MUHC
Are You a Good Fit for This Trial?
This trial is for women with a prolapse condition (anterior, uterine or apical) that's at least moderate in severity and needs surgery. It's not for those who are pregnant, don't speak English or French, have only posterior prolapse, can't attend follow-up visits, already have stress urinary incontinence, or had previous surgeries for incontinence or urethral repair.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Preoperative Assessment
Participants undergo preoperative prolapse reduction cough stress test to determine eligibility for anti-incontinence procedure
Surgical Intervention
Participants undergo POP surgical repair and intraoperative Crede maneuver to assess PONSUI risk and determine need for anti-incontinence procedure
Postoperative Follow-up
Participants are monitored for safety, effectiveness, and complications after surgery, including assessments at 6 weeks and 6 months
What Are the Treatments Tested in This Trial?
Interventions
- Intraoperative Crede Manoeuver
- Preoperative Prolapse Reduction Cough Stress Test
Find a Clinic Near You
Who Is Running the Clinical Trial?
McGill University Health Centre/Research Institute of the McGill University Health Centre
Lead Sponsor
St. Mary's Research Centre, Montreal
Collaborator